Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
1.33M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
11.4M
-
Shares change
-
-2.32M
-
Total reported value, excl. options
-
$57.4M
-
Value change
-
-$12.4M
-
Number of buys
-
14
-
Number of sells
-
-13
-
Price
-
$5.06
Significant Holders of Galecto, Inc. - Common Stock, par value $0.00001 per share (GLTO) as of Q2 2021
31 filings reported holding GLTO - Galecto, Inc. - Common Stock, par value $0.00001 per share as of Q2 2021.
Galecto, Inc. - Common Stock, par value $0.00001 per share (GLTO) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.4M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.09M shares), Novo Holdings A/S (2.5M shares), Cormorant Asset Management, LP (1.75M shares), JANUS HENDERSON GROUP PLC (1.3M shares), Soleus Capital Management, L.P. (538K shares), MAVERICK CAPITAL LTD (356K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (208K shares), Laurion Capital Management LP (208K shares), GEODE CAPITAL MANAGEMENT, LLC (74.7K shares), and Asymmetry Capital Management, L.P. (61K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.